// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

TGF-beta induces ribosome activity, alters ribosome composition and inhibits ires-mediated translation in chondrocytes

G.G. van den Akker - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

methionine

A comprehensive transcriptional map of knee osteoarthritis

G. Katsoula - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Prognostic factors for radiographic and symptomatic tibiofemoral and patellofemoral osteoarthritis 32-37 years after anterior cruciate ligament injury

S.R. Filbay - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Foot symptom trajectories over seven years and relationship to potential prognostic factors: the clinical assessment study of the foot

M. Marshall - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Clinical trial data analysis of the placebo effect in osteoarthritis

J. Maier - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Mediators of the predictive relationship between a self-report measure of central mechanisms and future knee pain outcomes in the Knee Pain In the Community (KPIC) cohort

R. Matthews - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Comparative effectiveness of international osteoarthritis management program clinical cohorts: a project of the oarsi joint effort initiative in collaboration with the OA trial bank

J.P. Eyles - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Baseline characteristics of the applied public-private research enabling osteoarthritis clinical headway (approach) cohort

E.M. van Helvoort - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Cartilage repair activity during joint-preserving treatment may be accompanied by osteophyte formation

M.P. Jansen - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pain distant from the index site and sensitization in people with knee pain and low back pain

K. Akin-Akinyosoye - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Chronic low back pain

N/A

Patients' perspectives on flares in knee osteoarthritis: a qualitative study

E. Parry - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Persistent pain and upper extremity function in former collegiate baseball players: an exploratory analysis

G.S. Bullock - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Using multivariable mendelian randomization to estimate the bmi-independent causal effect of bone mineral density on osteoarthritis

A. Hartley - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Osteoarthritis

N/A

Determinants of fatigue among individuals with symptomatic knee osteoarthritis: the multicenter osteoarthritis study

H.O. Fawole - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Knee osteoarthritis

N/A

Subsequent risk of consultaton for other diseases after incident doctor-diagnosed knee or hip osteoarthritis: a population-based cohort study

K. Pihl - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

The association of sport participation with osteoarthritis. a systematic review and meta-analysis

T. Bestwick-Stevenson - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

Methadone hydrochloride

Is lesser trochanter size a novel risk factor for hip osteoarthritis? findings from the MROS study

B.G. Faber - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Occupation and risk of knee osteoarthritis and knee replacement: a longitudinal, multiple-cohort study

T.A. Perry - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Risk factors for the incidence of hand interphalangeal joint osteoarthritis- a systematic review

K. Shah - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Inflammatory Arthritis

N/A

The relation of physical activity with fatigue in persons with symptomatic knee osteoarthritis and its potential mediation by physical function or depressive symptoms: the most study

H.O. Fawole - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Knee osteoarthritis

N/A

Copyright © 2026. QuantiNova All rights reserved